Deep Intelligent Pharma announced that it has raised a US$15 million series B round of financing from Sequoia Capital China. It operates an artificial intelligence (AI) technology and blockchain technology driven platform, which helps pharmaceutical companies to accelerate drug discovery, development, and medical affairs.
Written by: Sophy Yang
Date: October 9, 2018
Read full article: ChinaMoneyNetwork